Intech, a leader in the manufacturing of orthopedic medical devices, has shared the news that Montagu has entered exclusive negotiations with Eurazeo to buy the company’s majority-stake, investing alongside the Intech management team.
 
The transaction will bolster Intech Group’s momentum in the wake of strategic acquisitions and continued investment in its operations which will reinforce Intech’s position as a game-changing player in the industry.
 
Intech Group is on-track to reach $145M in revenue by year-end 2021 thanks to continued investment in its 6 facilities worldwide. Through this new partnership, the Group is setting itself up to navigate today’s market and challenges. Intech is known for passion and energy by delivering unique solutions that better patients’ lives around the globe.
 
Entering a new partnership with Montagu will give Intech a new spark for growth, reinforcing its expansion initiatives while laying the foundations to get to the next level on its bold and ambitious journey. The Group is looking to expand its portfolio and its global reach while scaling-up its production and distribution capabilities and is convinced that Montagu is the right partner to help it achieve this.
 
The Intech Group takes pride in its aspirations but also in the quality of the products and services it offers to its customers. With enhanced production capacities and a strong international presence, Intech is determined to reach new heights in the industry, offering customers increased agility and reactivity, all whilst maintaining its best-in-class customer experience.
 
Intech’s strategic road-map includes capitalizing on its unique know-how in the Robotics and Navigation space as well as investments in state-of-the-art technology such as 3D printing to accelerate time-to-market, for the future of orthopedics.
 
As such, Intech, with the support of its new shareholder, looks more than ever set to push the boundaries of orthopedics.